HUMDF Stock: Hua Medicine (Shanghai) Ltd. Stock Price, Analysis & Insights
Get live HUMDF stock price $0.43, comprehensive Hua Medicine (Shanghai) Ltd. stock analysis, charts, news, and expert forecast. Real-time HUMDF stock data and investment insights.
Loading chart data...
Hua Medicine (Shanghai) Ltd. (HUMDF) Overview
Hua Medicine (Shanghai) Ltd. (HUMDF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, HUMDF trades at $0.43 with a market capitalization of 430.90M . Over the past 52 weeks, HUMDF has traded between $0.15 and $0.50 , with the current price positioned at approximately 81% of this ...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 430.90M
- Current price: $0.43
- 52-week range: $0.15 - $0.50
- P/E ratio: 2.70
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Hua Medicine (Shanghai) Ltd. is a clinical-stage pharmaceutical firm specializing in treatments for diabetes, primarily targeting the Chinese market. Its flagship product is Dorzagliatin (also known as HMS5552), an oral medication currently being dev...
Company Information
- CEO
- Li Chen
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 168
Contact Information
- Website
- https://www.huamedicine.com
- Address
- Building A
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 2.7)
✓ Lower volatility stock (Beta: 0.80) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Hua Medicine (Shanghai) Ltd. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Hua Medicine (Shanghai) Ltd.
- ⚠Investors should consider how Hua Medicine (Shanghai) Ltd. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
430.90M
P/E Ratio (TTM)
2.70
Beta
0.80
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare HUMDF with peer companies:
- Price
- $0.13
- Market cap
- 655.46M
- Price
- $31.90
- Market cap
- 553.86M
- Price
- $6.19
- Market cap
- 312.18M
- Price
- $0.89
- Market cap
- 315.23M
- Price
- $2.90
- Market cap
- 245.80M
- Price
- $19.36
- Market cap
- 567.72M
- Price
- $6.59
- Market cap
- 646.05M
- Price
- $0.20
- Market cap
- 211.81M
- Price
- $1.86
- Market cap
- 453.24M
- Price
- $1.30
- Market cap
- 470.36M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.